Antares Pharma Inc (ATRS)
Market Closed
24 Apr, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
5. 59
+0.01
+0.1792%
$
- Market Cap
- P/E Ratio
- Div Yield
1.76M Volume
- Eps
$ 5.58
Previous Close 
Want to track ATRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Antares Pharma Inc (ATRS) Statistics
Valuation metrics
Market Cap -
Enterprise value -41.96M
Trailing P/E (ttm) 20.7
Forward P/E -
PEG ratio -0.61
Price/Sales (ttm) -
Price/Book (mrq) 5.41
Enterprise Value/Revenue -0.23
Enterprise Value/EBITDA -0.63
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 3.11
52-Week high 5.6
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 29 Jan 1999
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.25%
Operating margin 0.34%
Operational effectiveness
Return on assets 0.18%
Return on equity 0.31%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.08
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.27
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 2.74%
Book value per share (mrq) 1.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
